Coherus BioSciences Inc banner

Coherus BioSciences Inc
F:8C5

Watchlist Manager
Coherus BioSciences Inc Logo
Coherus BioSciences Inc
F:8C5
Watchlist
Price: 1.481 EUR -10.35% Market Closed
Market Cap: €169.9m

Wall St Price Targets

8C5 Price Targets Summary
Coherus BioSciences Inc

Wall Street analysts forecast 8C5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 8C5 is 4.808 EUR with a low forecast of 3.361 EUR and a high forecast of 6.114 EUR.

Lowest Forecast
Price Target
3.361 EUR
127% Upside
Average Forecast
Price Target
4.808 EUR
225% Upside
Highest Forecast
Price Target
6.114 EUR
313% Upside
Coherus BioSciences Inc Competitors:
Price Targets
EOLS
Evolus Inc
123% Upside
WLFC
Willis Lease Finance Corp
-8% Downside
PTEN
Patterson-UTI Energy Inc
-2% Downside

Revenue
Forecast

25% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
25% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-58%
Average Miss
N/A
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-58%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 6%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 8C5's stock price target?
Price Target
4.808 EUR

According to Wall Street analysts, the average 1-year price target for 8C5 is 4.808 EUR with a low forecast of 3.361 EUR and a high forecast of 6.114 EUR.

What is the Revenue forecast for Coherus BioSciences Inc?
Projected CAGR
46%

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.

What is the Net Income forecast for Coherus BioSciences Inc?
Projected CAGR
6%

The compound annual growth rate for Net Income over the next 8 years is 6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett